The efficacy of collagens can vary wildly, due to various factors, including: type, source, molecular composition, molecular weight, and manufacturing process. Clinically established for its high efficacy, Biocell Collagen is a unique, synergistic ingredient that serves to elevate this booming segment of the market through a multitude of parameters.
Valued at US$9.76 billion in 2023, the global collagen market is anticipated to expand at a 9.6% compound annual growth rate (CAGR) from 2024 to 20301, with areas of application that include: improving the texture and quality of hair, nails, and skin; strengthening joint health, alongside increasing protein content in sports nutrition and functional foods and beverages.
However, not all collagens are created equal, and this insightful white paper will outline:
The clinically established, complex matrix of molecules that makes BioCell Collagen so much more efficacious than an isolated or purified collagen protein.
The unique sources of this synergistic ingredient, which converge to closely mirror the composition of human articular cartilage.
How BioCell Collagen leverages upon the superiority of a clean, desirable source of type II collagen.
The stringent quality assurance procedures undertaken in the manufacturing of BioCell Collagen.
Details of BioCell Collagen’s own BioOptimizedTM process and its impressive outcome in terms of bioavailability in human subjects.
How multiple gold-standard clinical trials demonstrate that BioCell Collagen significantly improves joint pain and the ability to engage in physical activities, as well as promoting workout recovery.
The impressive results of studies examining how BioCell Collagen promotes skin health, including significant reductions in wrinkles and transepidermal water loss, and significant increases in skin elasticity and hyaluronic acid content.
Download the exclusive white paper here.